The protective action of amlodipine on cardiac negative inotropism caused by prolonged incubation in vitro

Life Sciences

Volumn 63, Issue 21, 1998, Pages 1849-1861

  Bravo, Guadalupe ^a   Hong, Enrique ^a   Larios, Francisco ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Amlodipine; Calcium channels; Myocardial contractility; Protective effect

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; ISOPRENALINE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; HEART CONTRACTION; HEART FAILURE; HEART PROTECTION; HEART RATE; INOTROPISM; MALE; NONHUMAN; RAT; VASCULAR RING;

AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; CALCIUM CHANNEL BLOCKERS; ELECTRIC STIMULATION; HEART VENTRICLES; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR FUNCTION, RIGHT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032538499     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00461-5     Document Type: Article

References (24)

1. 1. M. BENTFELD, H. LÜLLMANN, T. PETERS and D. PROPPE, Br. J. Pharmacol. 61 19 (1977).
2. 2. E.S. BLESA, A.G. LANGER, A.A. BRADY and S.A. SERENA, Am. J. Physiol. 219 747 (1970).
3. 3. G. BRUM, W. OSTERRIEDER and W. TRAUTWEIN, Pflügers Arch. 401 111-118 (1984).
4. 4. R.A. BURGES, M. G. DODD and D.G. GARDINER, Am. J. Cardio. 64 101-201 (1989)
5. 5. M. FINET, G. BRAVO and T. GODFRAIND, Eur J Pharmacol. 164 555-563 (1989).
6. 6. H.C. HARTZELL and R. FISCHMEISTER, Nature 323 273-275 (1986)
7. 7. S. JULIUS, J. Cardiovasc. Pharmacol. 12 (suppl 7): S27-33 (1988)
8. 8. S. KAZDA and A. KNORR, Pharmacology of anti-hypertensive therapeutics. Ganten D, Mulrow P.J. (Eds.) Berlin: Springer-Verlag 301-75 (1990).
9. 9. V. CRATE and STEJSKALOVA, Arch. Inst. Physiol. 68 152 (1960).
10. 10. R. WANG, L. WU, E. KARPINSKI and P. K.T. PANG, FEBS Lett. 282:331-334,1991
11. 11. P.-F. MERY, S.M. LOHMANN, U. WALTER and R. FISCHMEISTER, Proc. Natl. Acad. Sci. USA 88 1197-1201 (1991)
12. 12. N. MOREL and T. GODFRAIND, J. Pharmacol. Exp. Ther. 243 711-5 (1987)
13. 13. N. MOREL and T. GODFRAIND, J. Cardiovasc Pharmacol. 24 524-533 (1994)
14. 14. N. MOREL and T. GODFRAIND, Br. J. Pharmacol. 102 467-77 (1991)
15. 15. M. J. MULVANY, H. NILSSON and J.A. FLATMAN, J. Physiol. 332 363-73 (1982)
16. 16. W.G. NAYLER, Biochem Pharmacol. 43 39-46 (1992)
17. 17. K. ONO and W. TRAUTWEIN, J. Physiol. (Lond.) 443 387-404 (1991)
18. 18. R.H. SCHOTT and A.C. DOLPHIN, Nature 330 760-762 (1987)
19. 19. V.J.A. SCHOUTEN and H.E.D.J. TER KEURS, Pflügers Arch. 407 14-17 (1986)
20. 20. D.S. WINLAW, G.A. SMYTHE, A.M. KEOGH, C.G. SCHYVENS, P.M. SPRATT and P.S. MACDONALD, Lancet 344 (8919): 373-4 (1994)
21. 21. A.M. BROWN, D.L. KUNZE and A. YATANI, J. Physiol. (Lond) 379 495-514 (1986)
22. 22. V.B. SCHINI and P.M. VANHOUTTE, J. Pharmacol. Exp. Ther. 261 553-559, 1992
23. 23. D.D. REES, R.M.J. PALMER, R. SCHULZ, H.F. HODSON and S. MONCADA, Br. J. Pharmacol 101 746-752,1990
24. 24. G. BRAVO, Pharmacology Communications 7, 287-291, 1996.